Psychobiotic Supplements Market - 2026-2033

July 2026 | 50 pages | ID: P6543D6401CDEN
DataM Intelligence

Abstracts

Psychobiotic Supplements Market reached US$532.24 million in 2025 and is expected to reach US$2,628.00 million by 2033, growing with a CAGR of 21.20% during the forecast period 2026-2033.

The Psychobiotic Supplements Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Psychobiotic Supplements Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Form

• Powder*
• Capsules
• Liquid
• Tablets

By Application

• Food Supplements*
• Dietary Supplements
• Infant Formula
• Nutritional Supplements

Regional Analysis for Psychobiotic Supplements Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Psychobiotic Supplements Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Form
3.2. Snippet by Application
3.3. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. XX
    4.1.1.2. XX
  4.1.2. Restraints
    4.1.2.1. XX
    4.1.2.2. XX
  4.1.3. Opportunity
    4.1.3.1. XX
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. BY FORM

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  6.1.2. Market Attractiveness Index, By Form
6.2. Powder*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Capsules
6.4. Liquid
6.5. Tablets

7. BY APPLICATION

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  7.1.2. Market Attractiveness Index, By Application
7.2. Food Supplements*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Dietary Supplements
7.4. Infant Formula
7.5. Nutritional Supplements

8. BY REGION

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  8.1.2. Market Attractiveness Index, By Region
8.2. North America
  8.2.1. Introduction
  8.2.2. Key Region-Specific Dynamics
  8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    8.2.5.1. U.S.
    8.2.5.2. Canada
    8.2.5.3. Mexico
8.3. Europe
  8.3.1. Introduction
  8.3.2. Key Region-Specific Dynamics
  8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    8.3.5.1. Germany
    8.3.5.2. UK
    8.3.5.3. France
    8.3.5.4. Italy
    8.3.5.5. Spain
    8.3.5.6. Rest of Europe
8.4. South America
  8.4.1. Introduction
  8.4.2. Key Region-Specific Dynamics
  8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    8.4.5.1. Brazil
    8.4.5.2. Argentina
    8.4.5.3. Rest of South America
8.5. Asia-Pacific
  8.5.1. Introduction
  8.5.2. Key Region-Specific Dynamics
  8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    8.5.5.1. China
    8.5.5.2. India
    8.5.5.3. Japan
    8.5.5.4. Australia
    8.5.5.5. Rest of Asia-Pacific
8.6. Middle East and Africa
  8.6.1. Introduction
  8.6.2. Key Region-Specific Dynamics
  8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

9. COMPETITIVE LANDSCAPE

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. COMPANY PROFILES

10.1. Lifted Naturals*
  10.1.1. Company Overview
  10.1.2. Product Portfolio and Description
  10.1.3. Financial Overview
  10.1.4. Key Developments
10.2. Lallemand Health Solutions Inc.
10.3. Uplift Food Pty Ltd.
10.4. DuPont
10.5. BioGaia
10.6. Nature’s Bounty Co.
10.7. Life Extension
10.8. Kerry Group
10.9. Bened Biomedical Co., Ltd.
10.10. NEURAXPHARM(*LIST NOT EXHAUSTIVE)

11. APPENDIX

11.1. About Us and Services
11.2. Contact Us